Cargando…

Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine

Detalles Bibliográficos
Autores principales: Ricardo, Jose W., Lipner, Shari R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480201/
https://www.ncbi.nlm.nih.gov/pubmed/34611542
http://dx.doi.org/10.1016/j.jdcr.2021.09.009
_version_ 1784576420904697856
author Ricardo, Jose W.
Lipner, Shari R.
author_facet Ricardo, Jose W.
Lipner, Shari R.
author_sort Ricardo, Jose W.
collection PubMed
description
format Online
Article
Text
id pubmed-8480201
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84802012021-09-30 Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine Ricardo, Jose W. Lipner, Shari R. JAAD Case Rep Case Report Elsevier 2021-09-22 /pmc/articles/PMC8480201/ /pubmed/34611542 http://dx.doi.org/10.1016/j.jdcr.2021.09.009 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ricardo, Jose W.
Lipner, Shari R.
Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_fullStr Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_full_unstemmed Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_short Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
title_sort case of de novo nail psoriasis triggered by the second dose of pfizer-biontech bnt162b2 covid-19 messenger rna vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480201/
https://www.ncbi.nlm.nih.gov/pubmed/34611542
http://dx.doi.org/10.1016/j.jdcr.2021.09.009
work_keys_str_mv AT ricardojosew caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine
AT lipnersharir caseofdenovonailpsoriasistriggeredbytheseconddoseofpfizerbiontechbnt162b2covid19messengerrnavaccine